Advertisement

Rockland biotech EMD Serono Inc. and Fast Forward LLC, a National Multiple Sclerosis Society-created nonprofit organization, are awarding more than $1 million in funding to a second group of three research projects focused on early-stage MS drug discovery research.

The research for all the project proposals received by the two organizations refers specifically to central nervous system neuroprotection or repair strategies.

SOURCE

Advertisement
Advertisement